Sweden · Delayed Price · Currency is SEK Xvivo Perfusion AB Company Description
Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden.
It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermic, sub-normothermic, or a combination; XVIVO System (XPS), a comprehensive ex vivo lung perfusion (EVLP) platform that offers an overview of the entire process; and STEEN Solution, a buffered extracellular solution intended for the assessment of isolated lungs after removal from the donor in preparation for eventual transplantation into a recipient.
It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XPS Disposable Lung Kit that contains all the necessary devices and tubing to run a normothermic EVLP procedure on the XPS; XVIVO Organ Chamber, a sterile single-use container intended to be used as a temporary receptacle for isolated donor lungs; and XVIVO Lung Cannula Set, a sterile single-use set that connects isolated donor lungs to an extracorporeal perfusion system for ex-vivo assessment.
In addition, the company offers Kidney Assist that provides clinicians with a choice of perfusion protocols from hypothermic to normothermic perfusion; and Gisto, an integrated system for organ transportation.
It operates in Sweden; The Netherlands; The United States; Italy; North and South America; Asia/Pacific and Oceania; and internationally.
The company was incorporated in 1998 and is headquartered in Mölndal, Sweden.
| Country | Sweden |
| Founded | 1998 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 190 |
| CEO | Christoffer Rosenblad |
Contact Details
Address: Gemenskapens gata 9 Mölndal, 431 53 Sweden | |
| Phone | 46 3 17 88 21 50 |
| Website | xvivogroup.com |
Stock Details
| Ticker Symbol | XVIVO |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0004840718 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Lena Hagman B.Sc. | Chief Operating Officer and Deputy Chief Executive Officer |
| Christoffer Rosenblad | Chief Executive Officer |
| Kristoffer Nordstrom | Chief Financial Officer |
| Ylva Vihoj | Senior Vice President of Human Resources |
| Dr. Magnus Nilsson Ph.D. | Senior Advisor |
| Andreas Wallinder M.D., Ph.D. | Chief Medical Officer |
| Johan Holmstrom | Senior Vice President of Commercial Europe and RoW |
| Jaya Tiwari | Senior Vice President of Clinical and Regulatory Affairs North America |
| Mark Reade | Senior Vice President of North America |